Cell Microenvironment And Cell Culture Media Are Key Elements For An Improved CAR-T Therapy

To develop effective T cell-based therapies, manufacturers must carefully choose their cell culture media, as this selection is crucial for achieving optimal critical quality attributes. Here, a new serum-free T cell media, designed to overcome the barriers hindering CAR-T therapies, is introduced. NB-ROC™ improves process speed, lowers manufacturing costs, and enhances the quality of therapeutic doses. Explore the performance of NB-ROC™ and Physiologix™ in comparison to other commercially available products as well as the significance of transduction efficiency in CAR T-cell therapy.